GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer. - Müller J; Sofyali E; Schwarzmüller L; Aylon Y; Weizman E; Schlicker L; Kelly K; Borgoni S; Oz S; Stocker C; Burmester S; Wörner A; et al. (Clinical epigenetics, 2026)